Related Experiment Video
Updated: Jun 17, 2026

Fentanyl Analog Screening using LC-TIMS-TOF MS/MS
Published on: November 8, 2024
Case report: Oxymorphone-involved fatalities: a report of two cases
Iain M McIntyre1, James L Sherrard, Craig L Nelson
1County of San Diego Medical Examiner's Office, San Diego, California 92123, USA. Iain.McIntyre@sdcounty.ca.gov
Abstract:
There has been an increased awareness of illicit opiate abusers using the narcotic oxymorphone (Opana) by inhalation. Many laboratory screening techniques currently in use cannot detect oxymorphone in blood or urine. Consequently, biological specimens containing low to moderate concentrations of oxymorphone will likely go undetected. The circumstances, pathology findings, and toxicology results of two fatalities involving oxymorphone are presented. An opiate confirmation gas chromatography-mass spectrometry (GC-MS) procedure, described in detail was able to detected, confirm, and quantify oxymorphone in both subjects. The blood concentrations were 0.05 mg/L (50 microg/L) and 0.12 mg/L (120 microg/L).
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Toxidromes: Clinical Features
Pharmaceutical Poisoning: Potential Scenarios
Analgesia and Pain Management
Drug Toxicity: Risk factors
